Register entry

Veloxis Pharmaceuticals, Inc

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
30
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
tablet, extended release3
RouteNDCs
oral3
Labeller name on the listingNDCs
veloxis pharmaceuticals, inc3
Exclusivity

Patents and exclusivities

30
PatentProductCoversExpiry
10166190ENVARSUS XRtacrolimusproductMay 2028
10864199ENVARSUS XRtacrolimususeMay 2028
11110081ENVARSUS XRtacrolimususeMay 2028
11123331ENVARSUS XRtacrolimususeMay 2028
11419823ENVARSUS XRtacrolimusproductMay 2028
12083103ENVARSUS XRtacrolimususeMay 2028
12403095ENVARSUS XRtacrolimusproductMay 2028
9549918ENVARSUS XRtacrolimusproductMay 2028
8664239ENVARSUS XRtacrolimususeAug 2028
8685998ENVARSUS XRtacrolimusproductAug 2028
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
Envarsus XRTacrolimustablet, extended release, oral68992-3010NDA
Envarsus XRTacrolimustablet, extended release, oral68992-3040NDA
Envarsus XRTacrolimustablet, extended release, oral68992-3075NDA
Compare

Other companies listing tacrolimus

Enquiry

Common questions

Is Veloxis Pharmaceuticals, Inc FDA approved?
Veloxis Pharmaceuticals, Inc holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Veloxis Pharmaceuticals, Inc make?
3 products are listed under Veloxis Pharmaceuticals, Inc in the openFDA NDC Directory, most often as tablet, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.